Rilematovir
- Generic Name
- Rilematovir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H20ClF3N4O3S
- CAS Number
- 1383450-81-4
- Unique Ingredient Identifier
- NQ99E8OH3P
- Background
Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)).
- Associated Conditions
- -
- Associated Therapies
- -
A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT05155007
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Merksem, Belgium
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 5
- Registration Number
- NCT04978337
- Locations
- 🇺🇸
Pines Care Research Center Inc, Pembroke Pines, Florida, United States
🇺🇸Renovatio Clinical, The Woodlands, Texas, United States
🇺🇸Frontier Clinical Research, Morgantown, West Virginia, United States
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 28
- Registration Number
- NCT04583280
- Locations
- 🇧🇪
UZ Leuven, Leuven, Belgium
🇧🇬Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria
ðŸ‡ðŸ‡ºPetz Aladar Megyei Oktato Korhaz, GyÅ‘r, Hungary
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath